Scientists probe Brain's time cells with scopolamine in epilepsy patients

NCT ID NCT05594017

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study investigates how scopolamine, a drug known to affect memory, changes brain activity in people with epilepsy who are already undergoing brain monitoring for seizures. Sixty participants will receive either scopolamine or a placebo and perform memory tasks while their brain signals are recorded. The goal is to understand when and how the drug impacts memory formation and recall, which could shed light on memory disorders.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Scopolamine
What this could lead to
If successful, this study could reveal how certain drugs affect memory processes in the brain, potentially guiding future treatments for memory loss.
What could go wrong
This is a very early, small study (60 participants) focused on understanding brain activity, not testing a treatment. Results may not apply to the general population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT, MILD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cognitive disorder Cognitive Dysfunction epilepsy Memory Disorders visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Texas Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.